Research News

Genetic Testing Rates Found to be Low in Women With A History of Breast or Ovarian Cancer

(August 22, 2017) The Journal of Clinical Oncology recently published a study about the unmet need of genetic testing in women with breast and ovarian cancer…

Read on

FDA Approves New Indication and Formulation for Olaparib

(August 21, 2017) The US Food and Drug Administration (FDA) has granted full approval to olaparib tablets (Lynparza, AstraZeneca) for use as maintenance therapy for women with recurrent epithelial ovarian, fallopian tube, or primary peritoneal…

Read on

Age When Giving Birth and Oral Contraceptives Influence One’s Risk of Ovarian Cancer

(August 9, 2017) The International Journal of Cancer recently published an article on preliminary findings for two factors that influence one’s risk of ovarian cancer, namely the age at which a woman gives birth and the age at which she starts…

Read on

Updated Patient Resources for Ovarian Cancer from the National Comprehensive Cancer Network

(July 31, 2017) The National Comprehensive Cancer Network (NCCN), has updated and published guidelines for patients with ovarian cancer. There are two parts to the resource guide: The Guidelines for Patients and Quick Guides…

Read on

OCRFA Funded Project Has Breakthrough on Therapeutic Approach for Rare Ovarian Cancer

(July 27, 2017) Earlier this week, in Nature Cell Biology, researchers at The Wistar Institute published their findings about a few strategies to treat clear cell carcinoma…

Read on

USPSTF Does Not Recommend Ovarian Cancer Screening for General Population

(July 19, 2017) The United States Preventative Services Task Force (USPSTF) has once again recommended against screening for ovarian cancer in asymptomatic, average risk women…

Read on

Age-Specific Risk in Women with BRCA1 and BRCA2 Mutations

(June 30, 2017) Ten thousand women, most of whom are BRCA1 or BRCA2 positive, were analyzed by the University of Cambridge in order to find age specific risk for breast and ovarian cancers…

Read on

Study Focused on Neuropathy in Female Cancer Survivors

(June 23, 2017) A clinical trial published in the Journal of Clinical Oncology focused on a largely understudied area of cancer survivorship: chemotherapy-induced peripheral neuropathy (CIPN) in women…

Read on

An Analysis on the Quality of Life in Long Term Survivors of Advanced Stage Ovarian Cancer

(June 1, 2017) A study, published last month in Gynecologic Oncology, focused on an area of ovarian cancer that is rarely talked about: the quality of life (QOL) for long term survivors of advanced stage ovarian cancer. Woman surviving 8…

Read on

The Risk of Blood Clots and Ovarian Cancer

(May 25, 2017) A retrospective study, published earlier this month in Obstetrics & Gynecology, looked at when women with ovarian cancer developed blood clots…

Read on

The Positive Impact of Cognitive Behavior Therapy on Fear of Cancer Recurrence

(May 22, 2017) A recent study from the Netherlands found that a combination of cognitive behavior therapies had a positive effect on FCR, or Fear of Cancer Recurrence…

Read on

OCRFA Funded Study Determines the Importance of Tumor Antigen

(May 2, 2017) A study, published in Gynecologic Oncology, revealed the importance of tumor antigen NY-ESO-1 for ovarian cancer patients…

Read on